ACE and ACE2 alterations in congestive heart failure rats and intervention effect of benazepril
Shanjun Zhu
Abstract
Shanjun Zhu
Abstract
Objective To explore the expressions of ACE/ACE2 in congestive heart failure (CHF) rats after myocardial infarction and the treatment effect of benazepril,an angiotensin converting enzyme inhibitor. Methods The rat heart failure model was induced by acute myocardial infarction (AMI) through ligating the left anterior descending coronary artery. One month after operation,rats were randomized to CHF placebo group and benazepril group. Sham-operated rats were used as the control group. Then 8 weeks later the rats were evaluated for hemodynamic parameters,body mass and left ventricular mass index,ACE and ACE2 mRNA expressions by RT-PCR and their protein expressions by immunohistochemical methods. Results The mRNA and protein expressions of ACE and ACE2 were increased in CHF placebo group than sham-operation group (P0.01),and the ratio of ACE/ACE2 was elevated. The hemodynamic parameters of benazepril group improved significantly than CHF placebo group (P0.01). Furthermore,the levels of ACE mRNA and protein of benazepril group decreased significantly (P0.01),whereas the level of ACE2 mRNA and protein were increased (P0.01),therefore,the ratio of ACE/ACE2 decreased. Conclusion The mRNA and protein expressions of ACE and ACE2 were upregulated in CHF rats,and the ratio of ACE/ACE2 was elevated. Administer of benazepril can downregulate ACE expression and upregulate ACE2 expression,so the ratio of ACE/ACE2 decreases,which might be the another intervention mechanism of the drug.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the expressions of ACE/ACE2 in congestive heart failure (CHF) rats after myocardial infarction and the treatment effect of benazepril,an angiotensin converting enzyme inhibitor. Methods The rat heart failure model was induced by acute myocardial infarction (AMI) through ligating the left anterior descending coronary artery. One month after operation,rats were randomized to CHF placebo group and benazepril group. Sham-operated rats were used as the control group. Then 8 weeks later the rats were evaluated for hemodynamic parameters,body mass and left ventricular mass index,ACE and ACE2 mRNA expressions by RT-PCR and their protein expressions by immunohistochemical methods. Results The mRNA and protein expressions of ACE and ACE2 were increased in CHF placebo group than sham-operation group (P0.01),and the ratio of ACE/ACE2 was elevated. The hemodynamic parameters of benazepril group improved significantly than CHF placebo group (P0.01). Furthermore,the levels of ACE mRNA and protein of benazepril group decreased significantly (P0.01),whereas the level of ACE2 mRNA and protein were increased (P0.01),therefore,the ratio of ACE/ACE2 decreased. Conclusion The mRNA and protein expressions of ACE and ACE2 were upregulated in CHF rats,and the ratio of ACE/ACE2 was elevated. Administer of benazepril can downregulate ACE expression and upregulate ACE2 expression,so the ratio of ACE/ACE2 decreases,which might be the another intervention mechanism of the drug.
Key concepts: Benazepril, Angiotensin-converting enzyme 2, Medicine, Internal medicine, Heart failure, ACE inhibitor, Placebo, Endocrinology